Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis
Open Access
- 15 June 2012
- journal article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 13 (1) , 103
Abstract
Idiopathic inflammatory myopathies (IIMs) are a rare group of autoimmune syndromes characterized by chronic muscle inflammation and muscle weakness with no known cause. Little is known about their incidence and prevalence. This study reports the incidence and prevalence of IIMs among commercially insured and Medicare and Medicaid enrolled populations in the US.Keywords
This publication has 18 references indexed in Scilit:
- The geoepidemiology of autoimmune muscle diseaseAutoimmunity Reviews, 2010
- Dermatomyositis and polymyositisAnnals of the New York Academy of Sciences, 2010
- Incidence of Dermatomyositis and Clinically Amyopathic DermatomyositisArchives of Dermatology, 2010
- Inclusion body myositis: old and new conceptsJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Evaluation and treatment of inflammatory myopathiesJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differencesAnnals of the Rheumatic Diseases, 2009
- Treatment of the inflammatory myopathies: update and practical recommendationsExpert Opinion on Pharmacotherapy, 2009
- Update on idiopathic inflammatory myopathiesAutoimmunity, 2006
- 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The NetherlandsNeuromuscular Disorders, 2004
- Myositis as a Cause of Muscle PainJournal of Musculoskeletal Pain, 1999